440 filings
Page 9 of 22
424B3
w7evbmnc4j f51oz3u
24 Apr 20
Prospectus supplement
4:05pm
DEFA14A
h3j6yh6xaptv
24 Apr 20
Additional proxy soliciting materials
6:09am
CORRESP
dkfay2h vz
22 Apr 20
Correspondence with SEC
12:00am
S-4/A
up4vjrxotp qo2izj
21 Apr 20
Registration of securities issued in business combination transactions (amended)
5:09pm
UPLOAD
rrm6vim
14 Apr 20
Letter from SEC
12:00am
8-K
2i9mdu llglw6kt
8 Apr 20
Departure of Directors or Certain Officers
4:05pm
S-4
wbo58gi8jiz2m
6 Apr 20
Registration of securities issued in business combination transactions
5:24pm
425
givfh t5y38
25 Mar 20
Business combination disclosure
4:01pm
425
r4tfhe xwq3z3s2
17 Mar 20
Business combination disclosure
12:00am
425
3ezm7in
16 Mar 20
Business combination disclosure
4:10pm
S-8
qiw1d h9k
16 Mar 20
Registration of securities for employees
4:08pm
8-K
e8sb1svsyj 8u
16 Mar 20
AcelRx Pharmaceuticals to Acquire Tetraphase Pharmaceuticals
3:24pm
425
91y0yhixoqdkn
16 Mar 20
Business combination disclosure
3:22pm
8-K
bu1zcm2
16 Mar 20
AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
7:40am
8-K
wasiehw
13 Jan 20
AcelRx Announces Year-End 2019 MetricsĀ and Provides Corporate Updates
7:06am
UPLOAD
47ghqvb7mx8e60c3d7
25 Nov 19
Letter from SEC
12:00am
CORRESP
grfw38jo
7 Nov 19
Correspondence with SEC
12:00am